To explore the value that specific novel models of care (MoC) incorporating values-based healthcare (VBHC) principles add to inflammatory bowel disease (IBD) care provision.
Key Findings:
Traditional care models do not meet the multifaceted needs of IBD patients, highlighting the necessity for innovative approaches.
VBHC prioritizes patient outcomes and evaluates costs to calculate the value of care delivery, demonstrating its potential advantages.
Novel care models incorporating VBHC principles have shown potential in improving clinical outcomes and reducing costs, with specific examples to be detailed.
Interpretation:
Implementing VBHC in IBD care can enhance patient outcomes and cost-effectiveness, addressing the rising prevalence and economic burden of IBD, while also improving overall care quality.
Limitations:
Lack of standardized measures for assessing value in healthcare, which complicates the evaluation of VBHC effectiveness.
Limited existing data on the cost-effectiveness of VBHC models specifically for IBD, necessitating further investigation.
Conclusion:
Adopting VBHC principles in IBD management can lead to improved sustainability and patient-centered care, although further research is needed to establish standardized measures and economic benefits, particularly in specific contexts.
